In Brief: Diagnostic Solutions safety alert
This article was originally published in The Gray Sheet
Diagnostic Solutions safety alert: FDA notifies retailers and health care facilities nationwide on Oct. 11 that, despite a blood glucose test strip recall issued by Diagnostic Solutions in January and June 195, "FDA and the manufacturer have recently found recalled strips in some retail outlets and health care facilities, such as nursing homes." The strips pose a serious health risk to users, FDA says, because they may give inaccurate readings...
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.